Market revenue in 2023 | USD 3.7 million |
Market revenue in 2030 | USD 4.7 million |
Growth rate | 3.6% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.65% in 2023. Horizon Databook has segmented the Kuwait in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The market in Kuwait is expected to grow steadily due to increasing demand for accurate and reliable testing services. With a growing focus on quality assurance and compliance, IVD quality control plays a vital role in ensuring the competency & accuracy of tests in Kuwait.
The market is driven by the country's commitment to improving healthcare services, promoting R&D, and meeting international quality standards. The country is tackling the growing prevalence of chronic disorders with major advancements in its healthcare infrastructure. Therefore, the rising prevalence of target diseases is a major factor driving growth.
Kuwait has shown an increased emphasis on early diagnosis and screening for a better treatment outlook. Screening solutions have witnessed certain novel advancements with increased usage of effective diagnostics.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account